

Note 10	Share-Based Compensation

The Company recognized share-based compensation expense of $2.6 million and $1.6 million during the thirteen weeks and $8.4 million and $6.0 million during the thirty-nine weeks ended October 28, 2017 and October 29, 2016, respectively. In addition to share-based compensation expense, the Company recognized cash-based expense related to performance share units and cash awards granted under the performance share plans of zero and $0.4 million during the thirteen weeks and $0.1 million and $1.9 million during the thirty-nine weeks ended October 28, 2017 and October 29, 2016, respectively.

The Company had net issuances (repurchases) of 9,832 and (22,233) shares of common stock during the thirteen weeks ended October 28, 2017 and October 29, 2016, respectively, for restricted stock grants, stock performance awards issued to employees, stock options exercised and common and restricted stock grants issued to directors, net of forfeitures and shares withheld to satisfy the minimum tax withholding requirement. During the thirty-nine weeks ended October 28, 2017 and October 29, 2016, the Company issued 251,718 and 158,592 shares of common stock, respectively, related to these share-based plans.

Restricted Stock

The following table summarizes restricted stock activity for the periods ended October 28, 2017 and October 29, 2016:



	Thirteen Weeks Ended					Thirteen Weeks Ended
	October 28, 2017					October 29, 2016
			Weighted- Average Grant Date Fair Value					Weighted- Average Grant Date Fair Value
	Total Number of Restricted Shares					Total Number of Restricted Shares
	Total Number of Restricted Shares					Total Number of Restricted Shares
July 29, 2017	1,194,326		$	28.03	July 30, 2016	1,139,299		$	25.42
Granted	25,000		27.13		Granted	6,500		25.18
Forfeited	(19,050	)	31.86		Forfeited	(29,500	)	24.87
Vested	(800	)	22.90		Vested	—		—
October 28, 2017	1,199,476		$	27.95	October 29, 2016	1,116,299		$	25.43

	Thirty-Nine Weeks Ended					Thirty-Nine Weeks Ended
	October 28, 2017					October 29, 2016
			Weighted- Average Grant Date Fair Value					Weighted- Average Grant Date Fair Value
	Total Number of Restricted Shares					Total Number of Restricted Shares
	Total Number of Restricted Shares					Total Number of Restricted Shares
January 28, 2017	1,128,049		$	25.85	January 30, 2016	1,262,449		$	19.55
Granted	381,312		26.92		Granted	357,100		26.54
Forfeited	(49,050	)	29.35		Forfeited	(78,000	)	23.67
Vested	(260,835	)	17.09		Vested	(425,250	)	9.22
October 28, 2017	1,199,476		$	27.95	October 29, 2016	1,116,299		$	25.43

All of the restricted shares granted during the thirteen weeks ended October 28, 2017 have a cliff-vesting term of four years. Of the 381,312 restricted shares granted during the thirty-nine weeks ended October 28, 2017, 4,492 shares have a cliff-vesting term of one year, 12,000 shares have a graded-vesting term of four years and 364,820 shares have a cliff-vesting term of four years. All of the restricted shares granted during the thirteen and thirty-nine weeks ended October 29, 2016 have a cliff-vesting term of four years. Share-based compensation expense for cliff-vesting grants is recognized on a straight-line basis over the respective vesting periods and expense for graded-vesting grants is recognized ratably over the vesting period.

Performance Share Awards

During the thirteen weeks ended October 28, 2017 and October 29, 2016, the Company granted no performance share awards. During the thirty-nine weeks ended October 28, 2017 and October 29, 2016, the Company granted performance share awards for a targeted 169,500 and 159,000 shares, respectively, with a weighted-average grant date fair value of $26.90 and $26.64, respectively. Vesting of performance-based awards is dependent upon the financial performance of the Company and the attainment of certain financial goals during the three-year period following the grant. At the end of the vesting period, the employee will have earned an amount of shares or units between 0% and 200% of the targeted award, depending on the achievement of the specified financial goals for the service period. Compensation expense is recognized based on the fair value of the award and the anticipated number of shares or units to be awarded for each tranche in accordance with the vesting schedule of the units over the three-year service period. During the first quarter of 2017, the Company's remaining performance share awards granted in units vested and were settled in cash at fair value. Refer to Note 13 to the condensed consolidated financial statements for further discussion regarding performance share units.

Stock Options

The following table summarizes stock option activity for the periods ended October 28, 2017 and October 29, 2016:



	Thirteen Weeks Ended					Thirteen Weeks Ended
	October 28, 2017					October 29, 2016
			Weighted- Average Grant Date Fair Value					Weighted- Average Grant Date Fair Value
	Total Number of Stock Options					Total Number of Stock Options
	Total Number of Stock Options					Total Number of Stock Options
July 29, 2017	92,042		$	6.42	July 30, 2016	222,790		$	8.98
Granted	—		—		Granted	—		—
Exercised	(6,000	)	6.41		Exercised	—		—
Forfeited	—		—		Forfeited	(2,250	)	15.94
Expired	(1,000	)	8.33		Expired	(15,000	)	9.82
October 28, 2017	85,042		$	6.39	October 29, 2016	205,540		$	8.85

	Thirty-Nine Weeks Ended					Thirty-Nine Weeks Ended
	October 28, 2017					October 29, 2016
			Weighted- Average Grant Date Fair Value					Weighted- Average Grant Date Fair Value
	Total Number of Stock Options					Total Number of Stock Options
	Total Number of Stock Options					Total Number of Stock Options
January 28, 2017	150,540		$	9.36	January 30, 2016	301,295		$	8.95
Granted	—		—		Granted	—		—
Exercised	(17,250	)	5.97		Exercised	(56,381	)	7.41
Forfeited	—		—		Forfeited	(9,749	)	15.94
Expired	(48,248	)	15.79		Expired	(29,625	)	10.27
October 28, 2017	85,042		$	6.39	October 29, 2016	205,540		$	8.85

Restricted Stock Units for Non-Employee Directors

Equity-based grants may be made to non-employee directors in the form of cash-equivalent restricted stock units ("RSUs"). The RSUs earn dividend equivalents at the same rate as dividends on the Company's common stock. The dividend equivalents, which vest immediately, are automatically re-invested in additional RSUs. Expense is recognized at fair value when the dividend equivalents are granted. The Company granted 838 and 1,086 RSUs to non-employee directors for dividend equivalents during the thirteen weeks ended October 28, 2017 and October 29, 2016, respectively, with weighted-average grant date fair values of $30.68 and $24.98, respectively. The Company granted 47,550 and 55,250 RSUs, including 2,630 and 3,050 RSUs for dividend equivalents, during the thirty-nine weeks ended October 28, 2017 and October 29, 2016, respectively, with weighted-average grant date fair values of $27.86 and $21.78, respectively.